CeriBell Inc.
Last updated September 27, 2026
Organization details
- Legal name
- CeriBell Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Sunnyvale
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CBLL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001861107
- EIN
- 47-1785452
Board of directors
-
Bakker Juliet Tammenoms · DirectorSince 2024
-
Erica J. Rogers · DirectorSince 2025
-
Josef Parvizi · DirectorSince 2024
-
Joseph Michael Taylor · DirectorSince 2024
-
Lucian Iancovici · DirectorSince 2024
-
Rebecca B. Robertson · DirectorSince 2024
-
Sharon O'keefe · DirectorSince 2026
-
Thomas A. West · DirectorSince 2026
-
William W. Burke · DirectorSince 2024
-
Xingjuan Chao · Director · President and CEOSince 2024
Chief executives
Xingjuan Chao
· President and CEO
Dates unknown
Director election results
Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.8%
-
91.8%
Board connections
8 of this board's directors also sit on 11 other boards.
- via Sharon O'keefe and William W. Burke
- via Lucian Iancovici
- via Joseph Michael Taylor
- via Thomas A. West
- via Thomas A. West
- via Bakker Juliet Tammenoms
- via Thomas A. West
- via Erica J. Rogers
- via Lucian Iancovici
- via William W. Burke
- via Rebecca B. Robertson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $22,947,248
- 100 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Blumberg Scott Officer (Chief Financial Officer) | Option exercise | +846 | $9.41 | $7,961 |
| Sep 15, 2026 | Xingjuan Chao Director, Officer (President and CEO) | Open-market sale | −20,846 | $25.03 | $521,775 |
| Sep 15, 2026 | Blumberg Scott Officer (Chief Financial Officer) | Open-market sale | −846 | $25.00 | $21,150 |
| Sep 8, 2026 | Woo Raymond Officer (Chief Technology Officer) | Option exercise | +8,389 | $2.24 | $18,791 |
| Sep 8, 2026 | Foehr David Officer (Senior VP, Finance and PAO) | Open-market sale | −1,755 | $24.26 | $42,576 |
| Sep 8, 2026 | Woo Raymond Officer (Chief Technology Officer) | Option exercise | +4,864 | $3.65 | $17,754 |
| Sep 8, 2026 | Foehr David Officer (Senior VP, Finance and PAO) | Option exercise | +7,500 | $4.70 | $35,250 |
| Sep 8, 2026 | Woo Raymond Officer (Chief Technology Officer) | Option exercise | +23 | $4.70 | $108 |
| Sep 8, 2026 | Foehr David Officer (Senior VP, Finance and PAO) | Open-market sale | −7,500 | $24.25 | $181,875 |
| Sep 8, 2026 | Woo Raymond Officer (Chief Technology Officer) | Open-market sale | −4,887 | $24.33 | $118,901 |
| Sep 2, 2026 | Blumberg Scott Officer (Chief Financial Officer) | Option exercise | +652 | $9.41 | $6,135 |
| Sep 2, 2026 | Xingjuan Chao Director, Officer (President and CEO) | Option exercise | +1,446 | $4.70 | $6,796 |
| Sep 2, 2026 | Blumberg Scott Officer (Chief Financial Officer) | Open-market sale | −652 | $25.00 | $16,300 |
| Sep 2, 2026 | Xingjuan Chao Director, Officer (President and CEO) | Option exercise | +23,554 | $4.70 | $110,704 |
| Sep 2, 2026 | Xingjuan Chao Director, Officer (President and CEO) | Open-market sale | −39,540 | $24.61 | $973,079 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.